insights_auto
Why is LONA up ၆.၉၇%?
Dive Deeperchevron_right
LONA:NASDAQ
LeonaBio Inc
၆.၆၀ US$
arrow_upward
+၆.၉၇%(+၀.၄၃) 1D
အောက် ၁၃, GMT-၄ ၁၃:၂၉:၀၇ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONA...
Open
၆.၀၆ US$
High
၆.၇၂ US$
Low
၅.၆၅ US$
Mkt. cap
၆.၂၁ ကုဋေ
Avg. vol.
၃.၅၇ သိန်း
Volume
၃.၇၈ သောင်း
52-wk high
၁၄.၁၉ US$
52-wk low
၂.၂၁ US$
EPS
-၁၉.၇၂ US$
Beta
၂.၁၁
Shares outstanding
၉.၄၂ သန်း
No. of employees
၁၉
Open
၆.၀၆ US$
High
၆.၇၂ US$
Low
၅.၆၅ US$
Mkt. cap
၆.၂၁ ကုဋေ
Avg. vol.
၃.၅၇ သိန်း
Volume
၃.၇၈ သောင်း
52-wk high
၁၄.၁၉ US$
52-wk low
၂.၂၁ US$
EPS
-၁၉.၇၂ US$
Beta
၂.၁၁
Shares outstanding
၉.၄၂ သန်း
No. of employees
၁၉
News stories
From web sources and news partners
巴士的報
·
ပြီးခဲ့သည့် ၁ နာရီ
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Tech Stocks Are Crushing the Market, but There's a Sneaky (and Dangerous) Risk for S&P 500 Investors
GV Wire
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
Wall Street Edges Lower as Chips Fall; Markets Assess Big Bank Earnings
CNBC
·
ပြီးခဲ့သည့် ၁ နာရီ
How options traders can prepare for a Nasdaq pullback
Profile
Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.
The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors.
Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." In 2025, the company paid a $4 million settlement in relation to allegations that the CEO falsified research to secure a federal grant. On October 21, 2021, Mark Litton, Ph.D., M.B.A. became chief executive officer. Wikipedia
About LeonaBio Inc
CEO-
Employees၁၉
Founded၂၀၁၁
HeadquartersBothell, ဝါရှင်တန်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteleonabio.com